United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Technology Industry News Can Rapidus Corporation really deliver 2nm mass production by 2027 with Japan’s backing? Rapidus Corporation secures 267.6 billion yen to push 2nm chip production by 2027. Discover what this means for Japan and global semiconductor power. bySrinathMarch 1, 2026